Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus (original) (raw)

• Garcia Frade LJ, dela Calle H, Alava l, Navarro JL, Creighton LJ, Gaffney PJ . Diabetes as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res 1987; 47: 533–540.
  Article CAS Google Scholar
• Colwell JA, Halushka PV . Platelet function in diabetes. Br J Haematol 1980; 44: 521–526.
  Article CAS Google Scholar
• Sims PJ, Faioni EM, Wiedmer T, Shattil SJ . Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205–18212.
  CAS PubMed Google Scholar
• Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes. Atherosclerosis 1995; 116: 235–240.
  Article CAS Google Scholar
• Nomura S . Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001; 74: 397–404.
  Article CAS Google Scholar
• Nomura S, Kanazawa S, Fukuhara S . Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with type 2 diabetes mellitus. J Diabetes Complicat 2003; 17: 153–159.
  Article Google Scholar
• Nomura S, Takahashi N, Inami N, Kajiura T, Yamada K, Nakamori H et al. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 2004; 174: 329–335.
  Article CAS Google Scholar
• Ogata N, Imaizumi M, Nomura S, Shouzu A, Arich M, Matsuoka M et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pr 2005; 68: 193–201.
  Article CAS Google Scholar
• Drake TA, Ruf W, Morrissey JH, Edgington TS . Functional tissue factor is entirely surface expressed on lipopolysaccharide stimulated human blood monocytes and a constitutively tissue factor producing neoplastic cell line. J Cell Biol 1989; 109: 389–394.
  Article CAS Google Scholar
• Osnes LTN, Westvik AB, Kieruf P . Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thromb Res 1994; 76: 373–383.
  Article CAS Google Scholar
• Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Esshewegw V et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 1994; 153: 3245–3255.
  CAS PubMed Google Scholar
• Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, Iwasaka T . Detection of monocyte-derived microparticles in patients with type II diabetes mellitus. Diabetologia 2002; 45: 550–555.
  Article CAS Google Scholar
• Nomura S, Kanazawa S, Fukuhara S . Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002; 16: 539–547.
  Article CAS Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T . Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 2005; 19: 551–557.
  Article CAS Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T, Fukuhara S . Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost 2004; 10: 205–215.
  Article CAS Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S, Iwasaka T . Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thromb Res 2006; 117: 385–392.
  Article CAS Google Scholar
• Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296–1301.
  Article CAS Google Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83.
  Article CAS Google Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetes patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.
  Article CAS Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930–1935.
  Article CAS Google Scholar
• Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein, adiponectin. Circulation 1999; 100: 2473–2476.
  Article CAS Google Scholar
• Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ . Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021–45026.
  Article CAS Google Scholar
• Hattori Y, Suzuki M, Hattori S, Kasai K . Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003; 46: 1543–1549.
  Article CAS Google Scholar
• Schulze MB, Rimm EB, Shai I, Ritai N, Hu FB . Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004; 27: 1680–1687.
  Article CAS Google Scholar
• Verhaar MC, Honing HL, van Dam T, Zwart M, Koomans HA, Kastelein JJ et al. Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. Cardiovasc Res 1999; 42: 752–760.
  Article CAS Google Scholar
• Berkels R, Eqink G, Marsen TA, Bartels H, Roesen R, Klaus W . Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension 2001; 37: 240–245.
  Article CAS Google Scholar
• The National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on Hypertension in diabetes. Hypertension 1994; 23: 145–158.
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert commitee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–1197.
• Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, Hughes JM et al. Microalbuminuria and coronary heart disease in non-insulin- dependent diabetes: an incidence study. Diabetes 1998; 47: 1786–1792.
  Article CAS Google Scholar
• Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M et al. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939–945.
  Article CAS Google Scholar
• Zucchelli P, Zuccala A, Borghi M, Fusaroli M, Sasdelli M, Stallone C et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452–458.
  Article CAS Google Scholar
• Kawata T, Hashimoto S, Koike T . Diversity in the renal hemodynamic effects of dihydropyridine calcium blockers in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1997; 30: 431–436.
  Article CAS Google Scholar
• Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237–1245.
  Article CAS Google Scholar
• Lupo E, Locher R, Weisser B, Vetter W . In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with _α_-tocopherol. Biochem Biophys Res Commun 1994; 203: 1803–1808.
  Article CAS Google Scholar
• Berkels R, Bertsch A, Breitenbach T . The calcium antagonist nifedipine stimulates endothelial NO release in therapeutical concentrations. Pharm Pharmcol Lett 1996; 2: 75–78.
  Google Scholar
• Kitakaze M, Asanuma H, Takashima S, Minamino T, Ueda Y, Sakata Y et al. Nifedipine-induced coronary vasodilation in ischemic hearts is attributable to bradykinin- and NO-dependent mechanisms in dogs. Circulation 2000; 101: 311–317.
  Article CAS Google Scholar
• Nyrop M, Zweifer AJ . Platelet aggregation in hypertension and the effects of antihypertensive treatment. J Hypertens 1988; 6: 263–269.
  Article CAS Google Scholar
• Ross R . Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–126.
  Article CAS Google Scholar
• Hjemdahl P, Larsson PT, Wallen NH . Effects of stress and β-blockade on platelet function. Circulation 1991; 84 (Suppl VI): VI-44–VI-61.
  CAS Google Scholar
• Sinzinger H, Virgolini I, Rauscha F, Fitscha P, O'Grady J . Isradipine improves platelet function in hypertensives. Eur J Clin Pharmacol 1992; 42: 43–46.
  Article CAS Google Scholar
• Tomoda F, Takata M, Kagitani S, Kinuno H, Yasumoto K, Tomita S et al. Effects of a novel calcium antagonist, benidipine hydrochloride, on platelet responsiveness to mental stress in patients with essential hypertension. J Cardiovasc Pharmacol 1999; 34: 248–253.
  Article CAS Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755–1762.
  CAS Google Scholar
• Mohlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer AF et al. Insulin decreases human plasma adiponectin levels. Horm Metab Res 2002; 34: 655–658.
  Article CAS Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T . Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus. Thromb Res 2005; 115: 277–285.
  Article CAS Google Scholar
• Taddei S, Virdis A, Ghiadomi L, Maganda A, Favilla S, Pompella A et al. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 2001; 37: 943–948.
  Article CAS Google Scholar
• Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T . 5-HT2A receptor antagonist increases circulating adiponectin in patients with type 2 diabetes. Blood Coag Fibrinolys 2005; 16: 423–428.
  Article CAS Google Scholar
• Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW . Retardation of aniographic progression of coronary artery disease by nifedipine (INTACT). Lancet 1990; 335: 1109–1113.
  Article CAS Google Scholar
• Waters D, Lesperance J, Francetich M, Causey D, Theroux P, Chiang YK et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940–1953.
  Article CAS Google Scholar